Lilly case id: (b)(4).This spontaneous case reported by a consumer who contacted the company to report adverse events, concerned a male patient of unknown age and origin.Medical history included being type i diabetic, being in insulin treatment and insulin glargine (lantus) as historical drug; also it caused him to have blood sugars out of control as it did not work.Concomitant medications included insulin glargine (toujeo) for unknown indication.The patient received insulin lispro (rdna origin) injections (humalog) via prefilled pen (kwikpen).Patient also received insulin lispro (rdna origin) injection (humalog) from cartridge via reusable device; humapen (unknown device).For both, indication for use, dosage regimen and start date were not reported.On unknown date, he was and old guy that got bad eyes and he did not feel secure about using the kwikpen as it did not click and he could not read the numbers without his glasses.Since unknown date, his blood sugars were out of control; they can go down to 20 and then he can go as high as 1200 (no units and normal ranges provided).The events of blood glucose increased and decreased were considered to be serious due to their medical significance.Information regarding corrective treatment, outcome of the event and the status of insulin lispro via kwikpen and the insulin lispro via cartridge were not reported.The operator of the kwikpen and humapen (unknown device) was the patient and his training status was not reported.The general and the suspect kwikpen and humapen (unknown device) duration of use were not reported.The action taken and the status of the kwikpen and humapen (unknown device) were not reported.The devices were not returned to the manufacturer.The reporting consumer did not provide assessment for the events and insulin lispro and/or the kwikpen or humapen (unkwnon device).Update 30jul2020: information received on 28jul2020 was contained in two different source documents that were processed at the same time.Update 11aug2020: entered a device specific safety summary (dsss) for the humapen (unknown device).Updated medwatch and european and (b)(6) fields for expedited device reporting.Corresponding fields and narrative updated accordingly.
|